Evaluation of Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stones, A Pivotal Trial

Status: Recruiting
Location: See all (15) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this study is to evaluate the safety and performance of the ELS to treat urinary stones. The ELS is intended to break urinary stones into small fragments that can pass during or after the procedure with less or no discomfort. Eligible patients are male or females, age 21 or older, with a single urinary stone in the ureter. Participants will undergo the ELS procedure and then be evaluated 30 days later for the presence or absence of urinary stone fragments on a CT scan. Other outcome measures will be changes in pain, quality of life, and return to normal daily activities/work.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 21
Healthy Volunteers: f
View:

• Male or Female aged \>=21 Years

• Provides written informed consent

• One urinary stone within the ureter, size \>=5 mm and \<=10 mm

• Stone is indicated for Shock Wavve Lithotrips Per AUA 2016 guidelines

• Urinary stone is present on a CT scan within past 14 days

Locations
United States
Arizona
Arizona State Urological Research Institute
RECRUITING
Phoenix
California
Michael G. Oefelein Clinical Trials
RECRUITING
Bakersfield
San Diego Clinical Trials
RECRUITING
La Mesa
Golden State Urology
RECRUITING
Sacramento
Florida
University of Miami Hospital
RECRUITING
Miami
Illinois
Comprehensive Urologic Care
RECRUITING
Lake Barrington
Kansas
Wichita Urology Group
RECRUITING
Wichita
North Carolina
Duke
RECRUITING
Durham
Nevada
Sheldon Freedman, MD
RECRUITING
Las Vegas
New York
University of Rochester Medical Center
RECRUITING
Rochester
SUNY - Upstate Medical University
RECRUITING
Syracuse
Texas
Urology San Antonio
RECRUITING
San Antonio
Virginia
University of Virginia
RECRUITING
Charlottesville
University of Virginia Community Health
RECRUITING
Culpeper
Urology of Virginia
RECRUITING
Virginia Beach
Contact Information
Primary
Louis Marcoux
louis.marcoux@avviomed.com
415-887-2037
Time Frame
Start Date: 2025-05-01
Estimated Completion Date: 2025-10
Participants
Target number of participants: 101
Treatments
Experimental: The ELS Trial is a prospective, multi-center, single arm study.
All Subjects who qualify to participate in the ELS Trial will receive the experimental ELS procedure.
Related Therapeutic Areas
Sponsors
Leads: Avvio Medical

This content was sourced from clinicaltrials.gov